RankingsPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Repurchases of common stock

KOBAYASHI PHARMACEUTICAL CO.,LTD.【JP:4967】

Market cap
¥428.3B
P/E ratio
38.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRepurchases of common stock (Million JPY)YoY (%)
Dec 31, 20240-100.00%
Dec 31, 2023-12,000-14.63%
Dec 31, 2022-14,056+256.48%
Dec 31, 2021-3,943-Infinity%
Dec 31, 20200-100.00%
Dec 31, 2019-8,014+58.13%
Dec 31, 2017-5,068-37.07%
Dec 31, 2016-8,054-0.68%
Mar 31, 2016-8,109+440.24%
Mar 31, 2015-1,501

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)